However, CM treatment effectively stimulated (p = 0.0123) the PPAR-γ proteins in the cardiac tissue of the NAFLD+CM group in comparison to the NAFLD group. The gene discussed is PPARG; the disease is metabolic dysfunction-associated steatotic liver disease.